Activity in Patients With Coronary Artery Disease : Relation to Endothelium-Dependent Electron Spin Resonance Characterization of Vascular Xanthine and NAD ( P ) H Oxidase

Stephan Spiekermann, Ulf Landmesser, Sergey Dikalov, Martin Bredt, Graciela Gamez, Helma Vasodilation Activity in Patients With Coronary Artery Disease : Relation to Endothelium-Dependent Electron Spin Resonance Characterization of Vascular Xanthine and NAD(P)H Oxidase Print ISSN: 0009-7322. Online ISSN: 1524-4539 Copyright © 2003 American Heart Association, Inc. All rights reserved. is published by the American Heart Association, 7272 Greenville Avenue, Dallas, TX 75231 Circulation doi: 10.1161/01.CIR.0000056762.69302.46 2003;107:1383-1389; originally published online March 3, 2003; Circulation. http://circ.ahajournals.org/content/107/10/1383 World Wide Web at: The online version of this article, along with updated information and services, is located on the

[1]  W. R. Taylor,et al.  Superoxide Production and Expression of Nox Family Proteins in Human Atherosclerosis , 2002, Circulation.

[2]  D. Harrison,et al.  Oxidant stress as a marker for cardiovascular events: Ox marks the spot. , 2001, Circulation.

[3]  T. Meinertz,et al.  Endothelial Dysfunction, Oxidative Stress, and Risk of Cardiovascular Events in Patients With Coronary Artery Disease , 2001, Circulation.

[4]  D. Harrison,et al.  Oxidative stress and vascular damage in hypertension , 2001, Coronary artery disease.

[5]  H. Drexler,et al.  Comparative Effect of ACE Inhibition and Angiotensin II Type 1 Receptor Antagonism on Bioavailability of Nitric Oxide in Patients With Coronary Artery Disease: Role of Superoxide Dismutase , 2001, Circulation.

[6]  Friedrich C. Luft,et al.  Endothelial Dysfunction and Xanthine Oxidoreductase Activity in Rats With Human Renin and Angiotensinogen Genes , 2001, Hypertension.

[7]  R. Busse,et al.  Endothelium-Derived Hyperpolarizing Factor Synthase (Cytochrome P450 2C9) Is a Functionally Significant Source of Reactive Oxygen Species in Coronary Arteries , 2001, Circulation research.

[8]  H. Drexler,et al.  Vascular extracellular superoxide dismutase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation. , 2000, Circulation.

[9]  K. Channon,et al.  Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors. , 2000, Circulation research.

[10]  A M Zeiher,et al.  Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. , 2000, Circulation.

[11]  S. Higano,et al.  Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. , 2000, Circulation.

[12]  B. Fink,et al.  A new approach for extracellular spin trapping of nitroglycerin-induced superoxide radicals both in vitro and in vivo. , 2000, Free radical biology & medicine.

[13]  Y. Hayashi,et al.  Expression of NADH/NADPH oxidase p22phox in human coronary arteries. , 1999, Circulation.

[14]  B. Fink,et al.  Comparison of glyceryl trinitrate-induced with pentaerythrityl tetranitrate-induced in vivo formation of superoxide radicals: effect of vitamin C. , 1999, Free radical biology & medicine.

[15]  J. Keaney,et al.  Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. , 1999, Circulation.

[16]  D. Harrison,et al.  Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. , 1999, Circulation.

[17]  S. Marklund,et al.  Binding of Xanthine Oxidase to Vascular Endothelium , 1999, The Journal of Biological Chemistry.

[18]  S. Vickers,et al.  Immunoaffinity localization of the enzyme xanthine oxidase on the outside surface of the endothelial cell plasma membrane. , 1998, Surgery.

[19]  D. Tosh,et al.  Xanthine oxidoreductase is asymmetrically localised on the outer surface of human endothelial and epithelial cells in culture , 1998, FEBS letters.

[20]  H. Drexler,et al.  Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure. , 1998, Circulation.

[21]  M. Benboubetra,et al.  A reappraisal of xanthine dehydrogenase and oxidase in hypoxic reperfusion injury: the role of NADH as an electron donor. , 1998, Free radical research.

[22]  A. Quyyumi,et al.  Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients. , 1997, Hypertension.

[23]  E. Bassenge,et al.  Spin trapping of superoxide radicals and peroxynitrite by 1-hydroxy-3-carboxy-pyrrolidine and 1-hydroxy-2,2,6, 6-tetramethyl-4-oxo-piperidine and the stability of corresponding nitroxyl radicals towards biological reductants. , 1997, Biochemical and biophysical research communications.

[24]  J A Thompson,et al.  Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[25]  G. Levine,et al.  Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. , 1996, Circulation.

[26]  J. Mehta,et al.  Increased secretion of tumor necrosis factor-alpha and interferon-gamma by mononuclear leukocytes in patients with ischemic heart disease. Relevance in superoxide anion generation. , 1994, Circulation.

[27]  D. Harrison,et al.  Hypercholesterolemia increases endothelial superoxide anion production. , 1993, The Journal of clinical investigation.

[28]  K. Hirano,et al.  Binding of human xanthine oxidase to sulphated glycosaminoglycans on the endothelial-cell surface. , 1993, The Biochemical journal.

[29]  U. Ryan,et al.  Regulation of xanthine dehydrogenase and xanthine oxidase activity and gene expression in cultured rat pulmonary endothelial cells. , 1992, The Journal of clinical investigation.

[30]  F. Stirpe,et al.  The regulation of rat liver xanthine oxidase. Conversion in vitro of the enzyme activity from dehydrogenase (type D) to oxidase (type O). , 1969, The Journal of biological chemistry.